APRIL LOCKAMY: Open Payments
NPI 1700324811 · LAKE CITY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 35 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $78 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $171 |
| PFIZER INC. | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 1 | $82 |
| Lilly USA, LLC | 4 | $64 |
| Intra-Sana Laboratories | 1 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Abbott Laboratories | 2 | $33 |
| Corcept Therapeutics | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Amgen Inc. | 2 | $29 |
Products named: Ozempic, FARXIGA, MOUNJARO, Wegovy, RELTONE 200 MG, TRINTELLIX, NURTEC ODT, ELIQUIS.
Industry payments across SC — which companies pay providers there.
